Literature DB >> 33462208

Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p/ICAM-1 axis.

Min Shi1, Zhao-Yun Li2, Li-Ming Zhang2, Xiao-Yu Wu2, Shi-Hao Xiang1, Yu-Gang Wang3, Ya-Qiong Zhang4.   

Abstract

Circular RNAs (circRNAs) is one type of important non-coding RNAs that participate in tumorigenesis and cancer progression. In our previous study, we performed a microarray analysis of circRNAs between the tumor tissues and the adjacent normal tissues of hepatocellular carcinoma (HCC) patients, and found that the circRNA hsa_circ_0007456 is significantly downregulated in the tumor tissues and correlated with the prognosis of HCC. We further investigated the relationship between the expression levels of hsa_circ_0007456 in HCC and the susceptibility of NK cells, and found that the expression levels of hsa_circ_0007456 in HCC cell lines significantly influenced their susceptibility to NK cells. Through a series of screening and validation, we found that hsa_circ_0007456 mainly functioned through sponging miR-6852-3p and regulating the expression of intercellular adhesion molecule-1 (ICAM-1) in HCC. The miR-6852-3p/ICAM-1 axis is essential for the NK cytotoxicity toward HCC mediated by hsa_circ_0007456. In conclusion, we identify here hsa_circ_0007456 as a promising biomarker of HCC, and highlight hsa_circ_0007456/miR-6852-3p/ICAM-1 axis as an important signaling pathway in the process of tumor immune evasion and the tumorigenesis of HCC.

Entities:  

Year:  2021        PMID: 33462208      PMCID: PMC7814008          DOI: 10.1038/s41419-020-03334-8

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  20 in total

Review 1.  Control of Metastasis by NK Cells.

Authors:  Alejandro López-Soto; Segundo Gonzalez; Mark J Smyth; Lorenzo Galluzzi
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

Review 2.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

Review 3.  A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.

Authors:  Miguel F Sanmamed; Lieping Chen
Journal:  Cell       Date:  2018-10-04       Impact factor: 41.582

Review 4.  NK cells for cancer immunotherapy.

Authors:  Noriko Shimasaki; Amit Jain; Dario Campana
Journal:  Nat Rev Drug Discov       Date:  2020-01-06       Impact factor: 84.694

Review 5.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

6.  Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

Authors:  De-Chen Lin; Anand Mayakonda; Huy Q Dinh; Pinbo Huang; Lehang Lin; Xiaoping Liu; Ling-Wen Ding; Jie Wang; Benjamin P Berman; Er-Wei Song; Dong Yin; H Phillip Koeffler
Journal:  Cancer Res       Date:  2017-02-20       Impact factor: 13.312

7.  Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.

Authors:  Xiaoming Lin; Yuhan Chen
Journal:  Med Sci Monit Basic Res       Date:  2018-04-30

Review 8.  Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.

Authors:  Chen Lu; Dawei Rong; Betty Zhang; Wubin Zheng; Xuehao Wang; Ziyi Chen; Weiwei Tang
Journal:  Mol Cancer       Date:  2019-08-29       Impact factor: 27.401

Review 9.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

Review 10.  The emerging landscape of circular RNA in life processes.

Authors:  Shibin Qu; Yue Zhong; Runze Shang; Xuan Zhang; Wenjie Song; Jørgen Kjems; Haimin Li
Journal:  RNA Biol       Date:  2016-08-11       Impact factor: 4.652

View more
  16 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

2.  The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Authors:  Huaru Zhang; Xiaofu Qiu; Guosheng Yang
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

3.  Circular RNA Circ-0003006 Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through Sponging miR-542-3p and Regulating HIF-1A.

Authors:  Qiang Tu; Xiaoxiang You; Jun He; Xuguang Hu; Changji Xie; Guohui Xu
Journal:  Cancer Manag Res       Date:  2021-10-13       Impact factor: 3.989

4.  ZNF652-Induced circRHOT1 Promotes SMAD5 Expression to Modulate Tumorigenic Properties and Nature Killer Cell-Mediated Toxicity in Bladder Cancer via Targeting miR-3666.

Authors:  Hu Ke; Jiabin Zhang; Fei Wang; Yunhe Xiong
Journal:  J Immunol Res       Date:  2021-12-09       Impact factor: 4.818

5.  [Research Progress of Circular RNAs in Tumor Immunotherapy].

Authors:  Chenyu Zhang; Lei Peng; Jingbin Ji; Wenjie Jiao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-10-11

Review 6.  The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.

Authors:  Chen Xue; Xinyu Gu; Zhengyi Bao; Yuanshuai Su; Juan Lu; Lanjuan Li
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

7.  CircNFIC Balances Inflammation and Apoptosis by Sponging miR-30e-3p and Regulating DENND1B Expression.

Authors:  Yangfeng Chen; Zhijun Wang; Xiaolan Chen; Xi Peng; Qinghua Nie
Journal:  Genes (Basel)       Date:  2021-11-19       Impact factor: 4.096

8.  Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.

Authors:  Binglin Cheng; Jingdong Tian; Yuhan Chen
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

Review 9.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

10.  Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.

Authors:  Xiao Liang; Rui Zhou; Yu Li; Lu Yang; Min Su; Keng Po Lai
Journal:  Aging (Albany NY)       Date:  2021-06-27       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.